Optimization Strategy of Carotid Artery Stenosis (COAS-CAS)

November 28, 2022 updated by: Peking Union Medical College Hospital

Cohort of Optimized Assessment Strategy of Carotid Artery Stenosis

The goal of this observational study is to learn about how to utilize multiple evaluation techniques in carotid artery stenosis patients for optimizing assessment of diagnosis and treatment strategy.

The main questions it aims to answer are:

  • Identify best strategy that use multi-modal MRI and CT to assess patients' cerebral lesions and perfusion.
  • Identify best strategy that use multi-modal MRI, PET-MRI ultrasound and CT to assess components and characters of patients' carotid plaques.

Participants will accept imaging examination before and after surgery. And doctors will collect basic characteristics, imaging results and biological samples of patients for analysis.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100730
        • Recruiting
        • vascular surgery department of PUMCH
        • Principal Investigator:
          • Bao Liu, MD
        • Principal Investigator:
          • Li Huo, MD
        • Contact:
        • Principal Investigator:
          • Zhichao Lai, MD
        • Principal Investigator:
          • Feng Feng, MD
        • Sub-Investigator:
          • Meiqi Wu, MD
        • Sub-Investigator:
          • Xiaoyuan Fan, MD
        • Sub-Investigator:
          • Ying Wang, MD
        • Sub-Investigator:
          • Li Zhang, MD
        • Sub-Investigator:
          • Liangrui Zhou, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Mild to severe carotid stenosis or near-occlusion patients receiving carotid revascularization treatment.

Description

Inclusion Criteria:

  1. patients with severe stenosis (≥50%) or near-occlusion diagnosed by computed tomographic angiogram;
  2. patients received carotid endarterectomy at Peking Union Medical College Hospital

Exclusion Criteria:

(1) Any contraindication to image examination; (3) refuse to sign the Informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Carotid artery stenosis
patient with carotid artery stenosis
All patients received carotid revascularization surgery at Peking Union Medical College Hospital.
Other Names:
  • carotid endarterectomy and carotid artery stent
Multi-modal MRI before and after surgery.
CTA before and after surgery.
PET/MRI before surgery.
Ultrasound before and after surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
stroke
Time Frame: During hospital stay, usually 7-30 days post operation
perioperative stroke
During hospital stay, usually 7-30 days post operation
cardiac infarction
Time Frame: During hospital stay, usually 7-30 days post operation
perioperative cardiac infarction
During hospital stay, usually 7-30 days post operation
transient ischemic attack
Time Frame: During hospital stay, usually 7-30 days post operation
perioperative transient ischemic attack
During hospital stay, usually 7-30 days post operation
cerebral hyperperfusion syndrome
Time Frame: During hospital stay, usually 7-30 days post operation
perioperative cerebral hyperperfusion syndrome
During hospital stay, usually 7-30 days post operation
death
Time Frame: During hospital stay, usually 7-30 days post operation
perioperative death
During hospital stay, usually 7-30 days post operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Image characters of MRI
Time Frame: half year after operation
Arterial transit times, cerebral blood flow, plaque characters, etc.
half year after operation
Image characters of PET/MRI
Time Frame: half year after operation
Diagnostic performance of 68Ga-FAPI PET/MR for intracranial or carotid atherosclerosis
half year after operation
Image characters of ultrasound
Time Frame: half year after operation
Diagnostic performance of carotid artery ultrasound for intracranial or carotid atherosclerosis
half year after operation
Carotid plaque characters
Time Frame: half year after operation
pathology characters of carotid plaque
half year after operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2015

Primary Completion (Anticipated)

December 31, 2025

Study Completion (Anticipated)

December 31, 2026

Study Registration Dates

First Submitted

April 10, 2022

First Submitted That Met QC Criteria

November 28, 2022

First Posted (Actual)

November 29, 2022

Study Record Updates

Last Update Posted (Actual)

November 29, 2022

Last Update Submitted That Met QC Criteria

November 28, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carotid Artery Stenosis

Clinical Trials on Carotid revascularization

3
Subscribe